Ingredion Misses Q3 2026 Earnings as Argo Recovery Stalls

Ingredion reported adjusted earnings per share of $2.28 for the third quarter of 2026, missing the $2.60 consensus estimate. Revenue came in at $1.79 billion, essentially in line with Wall Street's $1.80 billion expectation but down 1.3% from the same quarter a year earlier.

The core problem continues to be the Argo facility. Operating income in the Food and Industrial Ingredients U.S./Canada segment fell 36% year over year to $52 million, as high manufacturing costs persisted even though production remained stable for a second consecutive quarter. CEO Jim Zallie acknowledged the situation directly: 'Our third quarter results fell short of our expectations, largely due to Argo's slower than anticipated financial recovery, with incremental pressure from higher input costs and consumer softness.'

The Texture and Healthful Solutions segment saw operating income fall 10% to $95 million, hurt by rising tapioca costs. The Latin America segment faced its own headwinds from a stronger Mexican peso and disruptions tied to an earthquake in Colombia, though higher brewing and beverage volumes in Mexico and Brazil helped lift that segment's top line.

The guidance cut compounds the concern. Management lowered its full-year 2026 adjusted EPS outlook to a range of $9.25 to $9.70 and guided adjusted operating income down mid-teens, citing the slower Argo recovery, higher input costs, and softer consumer demand. The revision comes with shares already trading near 52-week lows, leaving little cushion for further disappointment.

Looking further out, Ingredion pointed to the pending acquisition of Tate and Lyle as a foundation for growth in 2027 and beyond. Integration planning is underway, though the deal still carries completion, antitrust, and integration risks, along with the added debt that would come with it. For now, the near-term story remains defined by how quickly Argo's cost structure can be brought under control.